女人书籍排行榜,大主宰

血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體

Monoclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

編號(hào)MAA145Hu21
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來(lái)源單抗制備
宿主小鼠
效價(jià)(克隆號(hào))E2
Ig亞型 IgG1 Kappa
純化方式蛋白A + 蛋白G親和純化
標(biāo)記物無(wú)標(biāo)記物
免疫原 RPA145Hu01-血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白
緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
性狀液體
濃度1mg/mL
且適物種-
應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。
下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
規(guī)格 20μl100μl 200μl 1ml 10ml
價(jià)格 ¥ 540 1260 ¥ 1260 ¥ 1800 ¥ 4500 ¥ 18000
欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

DAB staining on IHC-P; Sample: Human Colorectal cancer Tissue; Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Rectum Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Placenta Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Lung Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human VEGFC Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)

通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)VEGFC的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFC。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

贈(zèng)品

增值服務(wù)

抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
 細(xì)胞和組織染色液
 抗體陽(yáng)性對(duì)照品
 組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
 DAB顯色試劑盒
 SABC試劑盒
 長(zhǎng)臂生物素標(biāo)記試劑盒
 實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)

相關(guān)產(chǎn)品

編號(hào)	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA145Hu61	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)活性蛋白	Cell?culture;?Activity?Assays.
RPA145Hu01	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
RPA145Hu02	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu62	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu63	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu61	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
APA145Hu01	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)活性蛋白	Cell?culture;?Activity?Assays.
PAA145Hu01	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體	WB; IHC; ICC; IP.
MAA145Hu23	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu24	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu22	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu21	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MEA145Hu	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本)	Enzyme-linked immunosorbent assay for Antigen Detection.
SEA145Hu	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
SCA145Hu	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)	Chemiluminescent immunoassay for Antigen Detection.
LMA145Hu	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.
KSA145Hu01	血管內(nèi)皮生長(zhǎng)因子C(VEGFC)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)	Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Journal of Cellular Biochemistry	Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443]
genetics and molecular research	Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824]
Experimental and Therapeutic	Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498]
Am J Pathol	IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451]
PLoS One.	Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632]
Oncology?Letters	RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo. [pubmed:27895746]
Angiogenesis	Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235]
Oncology Reports	Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465]
LABORATORY INVESTIGATION	Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289]
Cutaneous and Ocular Toxicology	Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957]

留言咨詢